Introduction
Cette page fournit une analyse complète de l'historique des opérations d'initiés connues de Ernest Mario. Les initiés sont des dirigeants, des administrateurs ou des investisseurs importants dans une entreprise. Il est illégal pour les initiés d'effectuer des opérations d'initiés dans leur entreprise sur la base d'informations spécifiques et non publiques. Cela ne signifie pas qu'il est illégal pour eux d'effectuer toute transaction dans leur propre entreprise. Toutefois, ils doivent déclarer toutes les opérations à la SEC au moyen d'un formulaire 4. Malgré ces restrictions, les recherches universitaires indiquent que les initiés, en général, ont tendance à surperformer le marché dans leurs propres entreprises.
Rentabilité moyenne des opérations
La rentabilité moyenne des opérations est le rendement moyen de tous les achats effectués par l'initié sur le marché public au cours des trois dernières années. Pour ce faire, nous examinons tous les achats non planifiés effectués par l'initié sur le marché public, à l'exclusion de toutes les opérations d'initiés effectuées dans le cadre d'un plan de négociation 10b5-1. Nous calculons ensuite la performance moyenne de ces transactions sur 3, 6 et 12 mois, en faisant la moyenne de chacune de ces durées pour générer un indicateur de performance final pour chaque opération. Enfin, nous faisons la moyenne de tous les indicateurs de performance pour calculer un indicateur de performance pour l'initié. Cette liste ne comprend que les initiés ayant effectué au moins trois opérations d'initiés au cours des deux dernières années.
Si la rentabilité des opérations de cet initié est "N/A", cela signifie qu'il n'a pas effectué d'opérations d'achat sur le marché public au cours des trois dernières années, ou que les opérations qu'il a effectuées sont trop récentes pour permettre le calcul d'un indicateur de performance fiable.
Fréquence de mise à jour : Quotidienne
Entreprises ayant déclaré des positions d'initiés
Les dépôts de la SEC indiquent que Ernest Mario a déclaré des participations ou des opérations dans les entreprises suivantes :
Titre | Fonction | Dernières positions déclarées |
---|---|---|
US:SLNO / Soleno Therapeutics, Inc. | Director | 193 066 |
US:EYEN / Eyenovia, Inc. | Director | 9 653 |
Director | 49 000 | |
US:CELG / Celgene Corp. | Director | 0 |
US:TNXP / Tonix Pharmaceuticals Holding Corp. | Director | 50 000 |
US:CMRX / Chimerix, Inc. | Director | 108 167 |
US:BSX / Boston Scientific Corporation | Director | 86 032 |
US:XNPT / XenoPort, Inc. | Director | 0 |
US:928551AA8 / VIVUS, Inc. Bond | Director | 81 125 |
US:MAXY / Maxygen Inc | Director | 62 964 |
Comment interpréter les graphiques
Les graphiques suivants montrent la performance des titres après chaque opération non planifiée effectuée par Ernest Mario sur le marché public. Les opérations non planifiées sont des opérations qui n'ont pas été effectuées dans le cadre d'un plan de négociation 10b5-1. La performance des actions est représentée sous la forme d'une variation cumulée en pourcentage du cours de l'action. Par exemple, si une opération d'initié a été effectuée le 1er janvier 2019, le graphique montrera la variation quotidienne en pourcentage du titre jusqu'à aujourd'hui. Si le prix de l'action passait de 10 à 15 dollars pendant cette période, la variation cumulée en pourcentage du prix de l'action serait de 50 %. Une variation du cours de 10 à 20 dollars serait de 100 %, et une variation du cours de 10 à 5 dollars serait de -50 %.
Enfin, nous essayons de déterminer dans quelle mesure les opérations d'un initié sont en corrélation avec les rendements excédentaires (positifs ou négatifs) du cours de l'action, afin de déterminer si l'initié synchronise ses opérations pour tirer profit d'informations d'initié. Imaginons qu'un initié agisse de la sorte. Dans ce cas, nous nous attendrions soit (a) à des rendements positifs après les achats, soit (b) à des rendements négatifs après les ventes. Dans le cas (a), le graphique des ACHAT montrerait une série de courbes ascendantes, indiquant des rendements positifs après chaque transaction d'achat. Dans le cas (b), le graphique VENTE montre une série de courbes inclinées vers le bas, indiquant des rendements négatifs après chaque transaction de vente.
Toutefois, cela ne suffit pas pour tirer des conclusions. Si, par exemple, le cours de l'action de l'entreprise a connu une hausse non cyclique pendant de nombreuses années, nous nous attendrions à ce que tous les graphiques postérieurs à l'achat soient en pente ascendante. De même, des baisses non cycliques sur de nombreuses années se traduiraient par des graphiques post-achat en pente descendante. Aucun de ces graphiques ne suggère l'existence d'opérations d'initiés.
L'indicateur le plus fort serait une situation dans laquelle le prix de l'action serait extrêmement cyclique et où il y aurait à la fois des signaux positifs dans le graphique ACHAT et des courbes négatives dans le graphique VENTE. Cette situation suggère fortement la présence d'un initié qui planifie les opérations d'initiés de manière à en tirer un avantage financier.
Achats d'initiés HYPD / Hyperion DeFi, Inc. - Analyse des bénéfices à court terme
Dans cette section, nous analysons la rentabilité de chaque achat d'initié non planifié et effectué sur le marché public dans HYPD / Hyperion DeFi, Inc.. Cette analyse permet de comprendre si l'initié génère régulièrement des rendements anormaux et s'il vaut la peine d'être suivi. Cette analyse porte sur l'année qui suit chaque opération, tout en sachant que les résultats sont théoriques.
Le tableau suivant présente les achats les plus récents sur le marché public qui ne faisaient pas partie d'un plan de trading automatique.
Prix ajusté est le prix ajusté après fractionnement. Actions ajustées est le nombre d'actions ajustées après fractionnement.
Ventes d'initiés HYPD / Hyperion DeFi, Inc. - Analyse des pertes à court terme
Dans cette section, nous analysons la capacité à éviter les pertes à court terme lors de chaque vente d'initié non planifiée et réalisée sur le marché public dans HYPD / Hyperion DeFi, Inc.. Un modèle régulier d'évitement des pertes peut suggérer que les transactions de vente futures peuvent prédire des baisses de prix. Cette analyse porte sur un an après chaque opération, tout en sachant que les résultats sont théoriques.
Le tableau suivant présente les dernières opérations sur le marché public qui ne faisaient pas partie d'un plan de trading automatique.
Date de l'opération | Libellé | Initié | Actions déclarées |
Prix déclaré |
Actions ajustées |
Prix ajusté |
Coût de base | Jours jusqu'à Min |
Prix à Min |
Perte maximale évitée ($) |
Perte maximale évitée (%) |
---|---|---|---|---|---|---|---|
Il n'y a pas d'opérations d'initiés non planifiées connues sur le marché public pour cette combinaison d'initiés et de titres. |
Prix ajusté est le prix ajusté après fractionnement. Actions ajustées est le nombre d'actions ajustées après fractionnement.
Achats d'initiés SLNO / Soleno Therapeutics, Inc. - Analyse des bénéfices à court terme
Dans cette section, nous analysons la rentabilité de chaque achat d'initié non planifié et effectué sur le marché public dans HYPD / Hyperion DeFi, Inc.. Cette analyse permet de comprendre si l'initié génère régulièrement des rendements anormaux et s'il vaut la peine d'être suivi. Cette analyse porte sur l'année qui suit chaque opération, tout en sachant que les résultats sont théoriques.
Le tableau suivant présente les achats les plus récents sur le marché public qui ne faisaient pas partie d'un plan de trading automatique.
Prix ajusté est le prix ajusté après fractionnement. Actions ajustées est le nombre d'actions ajustées après fractionnement.
Ventes d'initiés SLNO / Soleno Therapeutics, Inc. - Analyse des pertes à court terme
Dans cette section, nous analysons la capacité à éviter les pertes à court terme lors de chaque vente d'initié non planifiée et réalisée sur le marché public dans HYPD / Hyperion DeFi, Inc.. Un modèle régulier d'évitement des pertes peut suggérer que les transactions de vente futures peuvent prédire des baisses de prix. Cette analyse porte sur un an après chaque opération, tout en sachant que les résultats sont théoriques.
Le tableau suivant présente les dernières opérations sur le marché public qui ne faisaient pas partie d'un plan de trading automatique.
Date de l'opération | Libellé | Initié | Actions déclarées |
Prix déclaré |
Actions ajustées |
Prix ajusté |
Coût de base | Jours jusqu'à Min |
Prix à Min |
Perte maximale évitée ($) |
Perte maximale évitée (%) |
---|---|---|---|---|---|---|---|
Il n'y a pas d'opérations d'initiés non planifiées connues sur le marché public pour cette combinaison d'initiés et de titres. |
Prix ajusté est le prix ajusté après fractionnement. Actions ajustées est le nombre d'actions ajustées après fractionnement.
Historique des opérations d'initiés
Ce tableau présente la liste complète des opérations d'initiés effectuées par Ernest Mario, telles que divulguées à la Securities Exchange Commission (SEC).
Date de dépôt | Date de l'opération | Formulaire | Libellé | Titre | Code | Actions | Actions restantes | Pourcentage de variation |
Prix de l'action |
Valeur de l'opération |
Valeur restante |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-06-10 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 6 500 | 193 066 | 3,48 | ||||
2024-05-23 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
X - Other | 62 000 | 186 566 | 49,77 | 4,50 | 279 000 | 839 547 | |
2024-01-10 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
G - Gift | -3 523 | 124 566 | -2,75 | ||||
2023-12-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
G - Gift | -8 700 | 128 089 | -6,36 | ||||
2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Warrant (right to buy) |
P - Purchase | 930 000 | 930 000 | |||||
2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Warrant (right to buy) |
P - Purchase | 930 000 | 930 000 | |||||
2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 930 000 | 930 000 | |||||
2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 930 000 | 930 000 | |||||
2022-02-02 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 56 338 | 1 433 135 | 4,09 | 0,36 | 20 000 | 508 763 | |
2021-11-22 |
|
4 | EYEN |
EYENOVIA, INC.
Stock Option (right to buy) |
A - Award | 9 653 | 9 653 | |||||
2021-11-22 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
A - Award | 6 963 | 382 706 | 1,85 | ||||
2021-11-02 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 26 888 | 1 376 797 | 1,99 | ||||
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 21 978 | 1 349 909 | 1,66 | 0,91 | 20 000 | 1 228 417 | |
2021-06-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Employee stock option (right to buy) |
A - Award | 31 862 | 31 862 | |||||
2021-05-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 16 529 | 1 176 416 | 1,43 | 1,21 | 20 000 | 1 423 463 | |
2021-02-02 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 8 928 | 1 157 804 | 0,78 | ||||
2021-01-22 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 49 000 | 49 000 | |||||
2021-01-19 |
|
4 | EYEN |
EYENOVIA, INC.
Class A Warrant |
X - Other | -41 216 | 0 | -100,00 | ||||
2021-01-19 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
X - Other | 41 216 | 375 743 | 12,32 | 2,27 | 93 560 | 852 937 | |
2021-01-12 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Employee stock option (right to buy) |
A - Award | 40 000 | 40 000 | |||||
2020-11-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 10 057 | 1 148 876 | 0,88 | 1,74 | 17 499 | 1 999 044 | |
2020-09-15 |
|
4 | EYEN |
EYENOVIA, INC.
Stock Option (right to buy) |
A - Award | 9 820 | 9 820 | |||||
2020-09-15 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
A - Award | 7 288 | 334 527 | 2,23 | ||||
2020-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 10 174 | 10 174 | 1,72 | 17 499 | 17 499 | ||
2020-05-20 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Employee stock option (right to buy) |
A - Award | 9 530 | 9 530 | |||||
2020-05-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 5 738 | 5 738 | 3,05 | 17 501 | 17 501 | ||
2020-03-26 |
|
4 | EYEN |
EYENOVIA, INC.
Class B Warrant |
P - Purchase | 61 823 | 61 823 | |||||
2020-03-26 |
|
4 | EYEN |
EYENOVIA, INC.
Class A Warrant |
P - Purchase | 41 216 | 41 216 | |||||
2020-03-26 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
P - Purchase | 82 431 | 327 239 | 33,67 | 2,27 | 187 118 | 742 833 | |
2020-01-24 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 10 448 | 10 448 | 3,35 | 35 001 | 35 001 | ||
2020-01-22 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 49 000 | 49 000 | |||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | -4 756 | 0 | -100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | -970 | 0 | -100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | -300 | 0 | -100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -13 266 | 0 | -100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -10 500 | 0 | -100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -11 000 | 0 | -100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -10 000 | 0 | -100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -20 700 | 0 | -100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
D - Sale to Issuer | -4 908 | 0 | -100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
D - Sale to Issuer | -62 884 | 0 | -100,00 | ||||
2019-08-20 |
|
4 | EYEN |
EYENOVIA, INC.
Stock Option (right to buy) |
A - Award | 9 057 | 9 057 | |||||
2019-08-20 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
A - Award | 8 038 | 280 779 | 2,95 | ||||
2019-07-15 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
P - Purchase | 35 971 | 272 741 | 15,19 | 2,78 | 99 999 | 758 220 | |
2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -375 | 0 | -100,00 | ||||
2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 375 | 62 884 | 0,60 | ||||
2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -300 | 300 | -50,00 | ||||
2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 300 | 62 509 | 0,48 | ||||
2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -484 | 970 | -33,29 | ||||
2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 484 | 62 209 | 0,78 | ||||
2019-06-12 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Employee stock option (right to buy) |
A - Award | 13 000 | 13 000 | |||||
2019-06-05 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 4 756 | 4 756 | |||||
2019-05-21 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
P - Purchase | 90 000 | 236 770 | 61,32 | 10,00 | 900 000 | 2 367 700 | |
2019-03-07 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
J - Other | 2 908 | 4 908 | 145,40 | 85,97 | 250 001 | 421 941 | |
2019-03-07 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
J - Other | -2 908 | 55 005 | -5,02 | 85,97 | -250 001 | 4 728 780 | |
2019-02-14 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
P - Purchase | 2 000 | 2 000 | 89,99 | 179 980 | 179 980 | ||
2019-02-14 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -5 100 | 57 913 | -8,09 | ||||
2019-02-05 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 49 000 | 49 000 | |||||
2018-12-20 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -8 600 | 0 | -100,00 | ||||
2018-12-20 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 8 600 | 63 013 | 15,81 | 59,06 | 507 873 | 3 721 233 | |
2018-11-28 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -10 000 | 8 600 | -53,76 | ||||
2018-11-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 10 000 | 54 413 | 22,52 | 59,06 | 590 550 | 3 213 360 | |
2018-10-31 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | -44 000 | 0 | -100,00 | ||||
2018-10-31 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | -833 | 0 | -100,00 | ||||
2018-10-31 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 44 000 | 169 000 | 35,20 | 3,45 | 151 800 | 583 050 | |
2018-10-31 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 833 | 125 000 | 0,67 | 1,37 | 1 141 | 171 250 | |
2018-08-13 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -12 000 | 44 413 | -21,27 | 92,32 | -1 107 888 | 4 100 386 | |
2018-07-26 |
|
4 | EYEN |
EYENOVIA, INC.
Stock Option (right to buy) |
A - Award | 4 465 | 4 465 | |||||
2018-07-26 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
A - Award | 4 033 | 146 770 | 2,83 | ||||
2018-06-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 16 500 | 50 000 | 49,25 | 4,48 | 73 920 | 224 000 | |
2018-06-26 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (Right to Buy) |
A - Award | 10 000 | 10 000 | |||||
2018-06-18 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -334 | 0 | -100,00 | ||||
2018-06-18 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 334 | 56 413 | 0,60 | ||||
2018-06-18 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Employee stock option (right to buy) |
A - Award | 15 931 | 15 931 | |||||
2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -375 | 375 | -50,00 | ||||
2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 375 | 56 079 | 0,67 | ||||
2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -300 | 600 | -33,33 | ||||
2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 300 | 55 704 | 0,54 | ||||
2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 13 266 | 13 266 | |||||
2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 1 454 | 1 454 | |||||
2018-06-13 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 20 000 | 20 000 | |||||
2018-06-13 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 3 606 | 475 324 | 0,76 | 2,04 | 7 356 | 969 661 | |
2018-06-13 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 500 | 471 718 | 0,11 | 2,04 | 1 020 | 962 305 | |
2018-06-13 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 4 980 | 471 218 | 1,07 | 2,05 | 10 209 | 965 997 | |
2018-06-11 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 14 803 | 466 238 | 3,28 | 2,04 | 30 257 | 952 990 | |
2018-06-11 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 4 611 | 451 435 | 1,03 | 2,00 | 9 234 | 903 999 | |
2018-06-07 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 1 200 | 446 824 | 0,27 | 2,05 | 2 460 | 915 989 | |
2018-06-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 1 300 | 445 624 | 0,29 | 2,05 | 2 665 | 913 529 | |
2018-06-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 500 | 444 324 | 0,11 | 2,05 | 1 025 | 910 864 | |
2018-05-29 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 500 | 443 824 | 0,11 | 2,01 | 1 005 | 892 086 | |
2018-05-29 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 5 000 | 443 324 | 1,14 | 2,05 | 10 250 | 908 814 | |
2018-05-22 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 5 000 | 438 324 | 1,15 | 1,94 | 9 720 | 852 102 | |
2018-05-22 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 25 000 | 433 324 | 6,12 | 1,95 | 48 750 | 844 982 | |
2018-05-21 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -15 000 | 108 167 | -12,18 | 4,81 | -72 142 | 520 229 | |
2018-05-21 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -30 000 | 123 167 | -19,59 | 4,80 | -143 931 | 590 918 | |
2018-05-21 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 25 000 | 408 324 | 6,52 | 1,90 | 47 500 | 775 816 | |
2018-05-17 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -30 000 | 153 167 | -16,38 | 4,79 | -143 808 | 734 221 | |
2018-05-16 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -30 000 | 183 167 | -14,07 | 4,69 | -140 808 | 859 713 | |
2018-05-15 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -22 553 | 213 167 | -9,57 | 4,67 | -105 232 | 994 637 | |
2018-05-15 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -22 857 | 235 720 | -8,84 | 4,63 | -105 766 | 1 090 747 | |
2018-05-15 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -7 143 | 258 577 | -2,69 | 4,57 | -32 614 | 1 180 637 | |
2018-05-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -2 815 | 265 720 | -1,05 | 4,60 | -12 949 | 1 222 312 | |
2018-04-24 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (Right to Buy) |
A - Award | 44 603 | 44 603 | |||||
2018-04-11 | 3 | KIN |
Kindred Biosciences, Inc.
Common Stock |
248 334 | ||||||||
2018-04-11 | 3 | KIN |
Kindred Biosciences, Inc.
Common Stock |
248 334 | ||||||||
2018-04-11 | 3 | KIN |
Kindred Biosciences, Inc.
Common Stock |
248 334 | ||||||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
G - Gift | 10 000 | 33 500 | 42,55 | ||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
G - Gift | -10 000 | 0 | -100,00 | ||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Units |
M - Exercise | -750 | 0 | -100,00 | ||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
M - Exercise | 750 | 64 572 | 1,18 | ||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Units |
M - Exercise | -750 | 0 | -100,00 | ||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
M - Exercise | 750 | 63 822 | 1,19 | ||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Units |
M - Exercise | -600 | 0 | -100,00 | ||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
M - Exercise | 600 | 26 648 | 2,30 | ||||
2018-02-26 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -13 370 | 55 404 | -19,44 | 94,49 | -1 263 298 | 5 234 985 | |
2018-02-26 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -2 250 | 324 | -87,41 | ||||
2018-02-26 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -2 250 | 324 | -87,41 | ||||
2018-02-07 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 8 689 | 704 352 | 1,25 | 1,73 | 15 000 | 1 215 923 | |
2018-01-24 | 3 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
285 474 | ||||||||
2018-01-24 | 3 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
285 474 | ||||||||
2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -5 000 | 23 500 | -17,54 | 3,46 | -17 300 | 81 310 | |
2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -8 965 | 28 500 | -23,93 | 3,44 | -30 840 | 98 040 | |
2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -6 035 | 37 465 | -13,87 | 3,51 | -21 183 | 131 502 | |
2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -10 000 | 43 500 | -18,69 | 3,57 | -35 700 | 155 295 | |
2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -5 000 | 53 500 | -8,55 | 3,55 | -17 750 | 189 925 | |
2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -1 967 | 55 467 | -3,42 | 3,58 | -7 042 | 198 572 | |
2017-11-01 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -13 600 | 0 | -100,00 | ||||
2017-11-01 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 13 600 | 71 024 | 23,68 | 31,80 | 432 412 | 2 258 208 | |
2017-10-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 28 846 | 1 873 174 | 1,56 | 0,52 | 15 000 | 974 050 | |
2017-08-31 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -12 000 | 57 424 | -17,29 | 121,24 | -1 454 880 | 6 962 086 | |
2017-08-14 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -18 506 | 69 424 | -21,05 | 130,52 | -2 415 403 | 9 061 220 | |
2017-07-17 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 24 590 | 1 844 328 | 1,35 | 0,61 | 15 000 | 1 125 040 | |
2017-07-05 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -734 | 0 | -100,00 | ||||
2017-07-05 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 734 | 87 930 | 0,84 | ||||
2017-06-30 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -6 105 | 5 895 | -50,88 | 4,28 | -26 117 | 25 219 | |
2017-06-29 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 6 341 | 6 341 | |||||
2017-06-29 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 21 000 | 21 000 | |||||
2017-06-21 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 20 000 | 20 000 | |||||
2017-06-20 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -333 | 334 | -49,93 | ||||
2017-06-20 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 333 | 87 196 | 0,38 | ||||
2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -375 | 750 | -33,33 | ||||
2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 375 | 86 863 | 0,43 | ||||
2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 900 | 900 | |||||
2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 10 500 | 10 500 | |||||
2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -3 570 | 86 488 | -3,96 | ||||
2017-05-09 |
|
4 | CAPN |
Capnia, Inc.
Employee stock option (right to buy) |
A - Award | 45 139 | 45 139 | |||||
2017-04-13 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
A - Award | 23 809 | 1 819 738 | 1,33 | 0,63 | 15 000 | 1 146 435 | |
2017-04-13 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
A - Award | 16 667 | 1 795 929 | 0,94 | 0,90 | 15 000 | 1 616 336 | |
2017-01-31 |
|
5 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -4 125 | 90 058 | -4,38 | ||||
2016-12-29 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -20 291 | 268 535 | -7,03 | 4,52 | -91 634 | 1 212 704 | |
2016-12-29 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -4 000 | 288 826 | -1,37 | 4,67 | -18 683 | 1 349 020 | |
2016-12-29 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -3 636 | 292 826 | -1,23 | 4,65 | -16 907 | 1 361 641 | |
2016-12-29 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | X | -72 073 | 296 462 | -19,56 | 4,68 | -337 143 | 1 386 790 |
2016-11-28 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 120 000 | 120 000 | 0,40 | 48 600 | 48 600 | ||
2016-10-31 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock Purchase Warrant |
P - Purchase | 100 000 | 100 000 | |||||
2016-10-31 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 100 000 | 630 724 | 18,84 | ||||
2016-10-11 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
A - Award | 15 625 | 1 779 262 | 0,89 | ||||
2016-09-26 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -15 000 | 90 058 | -14,28 | 109,42 | -1 641 300 | 9 854 146 | |
2016-09-14 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 100 000 | 530 724 | 23,22 | 0,79 | 79 180 | 420 227 | |
2016-08-19 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 25 000 | 1 763 637 | 1,44 | 0,99 | 24 750 | 1 746 001 | |
2016-08-19 |
|
4/A | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 5 637 | 1 688 637 | 0,33 | 1,20 | 6 764 | 2 026 364 | |
2016-08-19 |
|
4/A | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 43 169 | 1 683 000 | 2,63 | 1,18 | 50 875 | 1 983 416 | |
2016-08-19 |
|
4/A | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 50 000 | 1 738 637 | 2,96 | 1,24 | 62 000 | 2 155 910 | |
2016-07-05 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -733 | 734 | -49,97 | ||||
2016-07-05 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 733 | 105 058 | 0,70 | ||||
2016-06-28 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 9 634 | 9 634 | |||||
2016-06-28 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 9 000 | 9 000 | |||||
2016-06-28 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 50 000 | 381 440 | 15,09 | 3,70 | 184 845 | 1 410 146 | |
2016-06-21 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 50 000 | 430 724 | 13,13 | 2,00 | 100 000 | 861 448 | |
2016-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -333 | 667 | -33,30 | ||||
2016-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 333 | 104 325 | 0,32 | ||||
2016-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 1 125 | 1 125 | |||||
2016-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 11 000 | 11 000 | |||||
2016-06-13 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -2 068 | 0 | -100,00 | ||||
2016-06-13 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 068 | 103 992 | 2,03 | ||||
2016-06-10 |
|
4 | CAPN |
Capnia, Inc.
Employee stock option (right to buy) |
A - Award | 27 083 | 27 083 | |||||
2016-06-09 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 50 000 | 1 918 637 | 2,68 | 1,24 | 62 000 | 2 379 110 | |
2016-05-31 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Unit |
A - Award | 7 500 | 7 500 | |||||
2016-05-23 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 5 637 | 1 868 637 | 0,30 | 1,20 | 6 764 | 2 242 364 | |
2016-05-23 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 43 169 | 1 863 000 | 2,37 | 1,18 | 50 875 | 2 195 546 | |
2016-05-16 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 10 000 | 331 440 | 3,11 | 4,53 | 45 328 | 1 502 351 | |
2016-05-12 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 31 042 | 380 724 | 8,88 | 2,30 | 71 356 | 875 170 | |
2016-05-11 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 8 210 | 349 682 | 2,40 | 2,24 | 18 399 | 783 672 | |
2016-05-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 24 200 | 321 440 | 8,14 | 4,85 | 117 365 | 1 558 920 | |
2016-05-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 800 | 297 240 | 0,27 | 4,76 | 3 804 | 1 413 376 | |
2016-05-05 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1 761 | 15 845 | -10,00 | ||||
2016-05-05 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1 761 | 296 440 | 0,60 | 5,05 | 8 893 | 1 497 022 | |
2016-04-28 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -5 000 | 13 600 | -26,88 | ||||
2016-04-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 5 000 | 101 924 | 5,16 | 31,80 | 158 975 | 3 240 674 | |
2016-04-05 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1 760 | 17 606 | -9,09 | ||||
2016-04-05 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1 760 | 294 679 | 0,60 | 5,05 | 8 888 | 1 488 129 | |
2016-03-17 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
P - Purchase | 30 000 | 99 583 | 43,11 | 3,55 | 106 500 | 353 520 | |
2016-03-17 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 75 000 | 341 472 | 28,15 | 2,29 | 171 712 | 781 800 | |
2016-03-16 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 5 000 | 292 919 | 1,74 | 4,78 | 23 898 | 1 400 036 | |
2016-03-16 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 20 000 | 287 919 | 7,46 | 5,13 | 102 628 | 1 477 428 | |
2016-03-09 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1 761 | 19 366 | -8,34 | ||||
2016-03-09 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1 761 | 267 919 | 0,66 | 5,05 | 8 893 | 1 352 991 | |
2016-02-10 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Unit |
A - Award | 7 500 | 7 500 | |||||
2016-02-09 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1 760 | 21 127 | -7,69 | ||||
2016-02-09 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1 760 | 266 158 | 0,67 | 5,05 | 8 888 | 1 344 098 | |
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -18 600 | 0 | -100,00 | ||||
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 18 600 | 101 049 | 22,56 | 29,00 | 539 400 | 2 930 421 | |
2016-01-14 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1 761 | 22 887 | -7,14 | ||||
2016-01-14 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1 761 | 264 398 | 0,67 | 5,05 | 8 893 | 1 335 210 | |
2016-01-12 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 44 000 | 44 000 | |||||
2015-12-30 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 125 000 | 262 637 | 90,82 | 7,09 | 886 612 | 1 862 858 | |
2015-12-30 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -40 000 | 82 449 | -32,67 | 119,36 | -4 774 400 | 9 841 113 | |
2015-12-11 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1 760 | 24 648 | -6,66 | ||||
2015-12-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1 760 | 137 637 | 1,30 | 5,05 | 8 888 | 695 067 | |
2015-11-18 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 50 000 | 1 639 831 | 3,14 | 1,77 | 88 500 | 2 902 501 | |
2015-11-17 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | -125 000 | 86 032 | -59,23 | 17,63 | -2 203 162 | 1 516 340 | |
2015-11-10 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1 761 | 26 408 | -6,25 | ||||
2015-11-10 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1 761 | 135 877 | 1,31 | 5,05 | 8 893 | 686 179 | |
2015-10-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1 761 | 28 169 | -5,88 | ||||
2015-10-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1 761 | 134 116 | 1,33 | 5,05 | 8 893 | 677 286 | |
2015-09-14 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 15 000 | 1 589 831 | 0,95 | 2,28 | 34 200 | 3 624 815 | |
2015-09-08 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -832 | 8 319 | -9,09 | ||||
2015-09-08 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1 760 | 29 930 | -5,55 | ||||
2015-09-08 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 832 | 132 355 | 0,63 | 45,15 | 37 565 | 5 975 828 | |
2015-09-08 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1 760 | 131 523 | 1,36 | 5,05 | 8 888 | 664 191 | |
2015-08-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 10 000 | 260 472 | 3,99 | 6,05 | 60 500 | 1 575 856 | |
2015-08-26 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 1 468 | 250 472 | 0,59 | 6,40 | 9 395 | 1 603 021 | |
2015-08-25 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 16 228 | 1 553 999 | 1,06 | 1,91 | 30 995 | 2 968 138 | |
2015-08-25 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 2 532 | 249 004 | 1,03 | 6,20 | 15 698 | 1 543 825 | |
2015-08-20 |
|
4 | CAPN |
Capnia, Inc.
Warrant (right to buy) |
J - Other | -50 000 | 0 | -100,00 | ||||
2015-08-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
J - Other | 210 251 | 1 477 771 | 16,59 | ||||
2015-08-20 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 6 000 | 246 472 | 2,50 | 6,64 | 39 867 | 1 637 683 | |
2015-08-20 |
|
4/A | CAPN |
Capnia, Inc.
Common Stock |
J - Other | 210 251 | 1 537 771 | 15,84 | ||||
2015-08-17 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 15 000 | 240 472 | 6,65 | 6,93 | 104 018 | 1 667 553 | |
2015-08-13 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 10 000 | 1 327 520 | 0,76 | 1,64 | 16 440 | 2 182 443 | |
2015-08-12 |
|
4 | CAPN |
Capnia, Inc.
Warrant (right to buy) |
J - Other | -205 188 | 0 | -100,00 | ||||
2015-08-12 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 50 000 | 1 317 520 | 3,94 | 1,77 | 88 500 | 2 332 010 | |
2015-08-12 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
J - Other | 786 645 | 1 267 520 | 163,59 | ||||
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -832 | 9 151 | -8,33 | ||||
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -129 | 0 | -100,00 | ||||
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -750 | 0 | -100,00 | ||||
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -3 521 | 31 690 | -10,00 | ||||
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 832 | 129 763 | 0,65 | 45,15 | 37 565 | 5 858 799 | |
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 129 | 128 931 | 0,10 | 23,26 | 3 001 | 2 998 935 | |
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 750 | 128 802 | 0,59 | 23,26 | 17 445 | 2 995 935 | |
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 3 521 | 128 052 | 2,83 | 5,05 | 17 781 | 646 663 | |
2015-08-04 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -19 442 | 122 449 | -13,70 | 131,73 | -2 561 139 | 16 130 488 | |
2015-07-17 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 25 000 | 225 472 | 12,47 | 7,50 | 187 500 | 1 691 040 | |
2015-07-06 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -733 | 1 467 | -33,32 | ||||
2015-07-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 733 | 141 891 | 0,52 | ||||
2015-06-26 |
|
4 | CAPN |
Capnia, Inc.
Employee stock option (right to buy) |
M - Exercise | -54 999 | 0 | -100,00 | ||||
2015-06-26 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
M - Exercise | 54 999 | 480 875 | 12,91 | 3,48 | 191 397 | 1 673 445 | |
2015-06-24 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 9 983 | 9 983 | |||||
2015-06-19 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 1 000 | 1 000 | |||||
2015-06-19 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2015-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -2 068 | 0 | -100,00 | ||||
2015-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 068 | 141 158 | 1,49 | ||||
2015-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -2 066 | 2 068 | -49,98 | ||||
2015-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 066 | 139 090 | 1,51 | ||||
2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -258 | 129 | -66,67 | ||||
2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1 500 | 750 | -66,67 | ||||
2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -3 521 | 35 211 | -9,09 | ||||
2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 258 | 124 531 | 0,21 | 23,26 | 6 001 | 2 896 591 | |
2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1 500 | 124 273 | 1,22 | 23,26 | 34 890 | 2 890 590 | |
2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 3 521 | 122 773 | 2,95 | 5,05 | 17 781 | 620 004 | |
2015-06-08 |
|
4 | CAPN |
Capnia, Inc.
Employee stock option (right to buy) |
M - Exercise | -25 000 | 54 999 | -31,25 | ||||
2015-06-08 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
M - Exercise | 25 000 | 425 876 | 6,24 | 3,48 | 87 000 | 1 482 048 | |
2015-06-04 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | 8 750 | 11 250 | 350,00 | ||||
2015-06-04 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | 8 333 | 14 167 | 142,84 | ||||
2015-06-04 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 8 750 | 69 583 | 14,38 | 1,37 | 11 988 | 95 329 | |
2015-06-04 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common STock |
M - Exercise | 8 333 | 60 833 | 15,87 | 0,32 | 2 667 | 19 467 | |
2015-05-21 |
|
4 | XNPT |
XENOPORT INC
Non-Employee Restricted Stock Unit |
M - Exercise | -5 000 | 0 | -100,00 | ||||
2015-05-21 |
|
4 | XNPT |
XENOPORT INC
Common Stock |
M - Exercise | 5 000 | 88 750 | 5,97 | ||||
2015-05-19 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | -50 000 | 211 032 | -19,15 | 18,09 | -904 630 | 3 818 118 | |
2015-05-19 |
|
4 | CAPN |
Capnia, Inc.
Employee Stock Option |
A - Award | 5 000 | 5 000 | |||||
2015-05-07 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Deferred Stock Units |
A - Award | 10 650 | 10 650 | |||||
2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -130 | 387 | -25,15 | ||||
2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -750 | 2 250 | -25,00 | ||||
2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1 761 | 38 732 | -4,35 | ||||
2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 130 | 119 252 | 0,11 | 23,26 | 3 024 | 2 773 802 | |
2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 750 | 119 122 | 0,63 | 23,26 | 17 445 | 2 770 778 | |
2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1 761 | 118 372 | 1,51 | 5,05 | 8 893 | 597 779 | |
2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -258 | 517 | -33,29 | ||||
2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1 500 | 3 000 | -33,33 | ||||
2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -3 521 | 40 493 | -8,00 | ||||
2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 258 | 116 611 | 0,22 | 23,26 | 6 001 | 2 712 372 | |
2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1 500 | 116 353 | 1,31 | 23,26 | 34 890 | 2 706 371 | |
2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 3 521 | 114 853 | 3,16 | 5,05 | 17 781 | 580 008 | |
2015-03-06 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 4 000 | 200 472 | 2,04 | 6,57 | 26 280 | 1 317 081 | |
2015-02-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Unit |
A - Award | 6 000 | 6 000 | |||||
2015-02-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 5 000 | 5 000 | |||||
2015-02-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 30 000 | 196 472 | 18,02 | 5,85 | 175 500 | 1 149 361 | |
2015-02-04 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -7 666 | 0 | -100,00 | ||||
2015-02-04 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 7 666 | 137 024 | 5,93 | 27,69 | 212 272 | 3 794 195 | |
2015-01-28 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 44 000 | 44 000 | |||||
2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock (Right to Buy) |
M - Exercise | -258 | 775 | -24,98 | ||||
2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1 500 | 4 500 | -25,00 | ||||
2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -3 521 | 44 014 | -7,41 | ||||
2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 258 | 111 332 | 0,23 | 23,26 | 6 001 | 2 589 582 | |
2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1 500 | 111 074 | 1,37 | 23,26 | 34 890 | 2 583 581 | |
2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 3 521 | 109 574 | 3,32 | 5,05 | 17 781 | 553 349 | |
2015-01-13 |
|
4 | CAPN |
Capnia, Inc.
Employee Stock Option |
A - Award | 5 000 | 5 000 | |||||
2014-12-19 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Series A common stock purchase warrant |
X - Other | -30 000 | 0 | -100,00 | ||||
2014-12-19 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
X - Other | 30 000 | 166 472 | 21,98 | 4,25 | 127 500 | 707 506 | |
2014-12-02 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10 000 | 261 032 | -3,69 | 12,96 | -129 618 | 3 383 445 |
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series A Warrant to Purchase Common Stock |
P - Purchase | 253 846 | 597 232 | 73,92 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series B Warrant to Purchase Common Stock |
P - Purchase | 253 846 | 597 232 | 73,92 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series A Warrant to Purchase Common Stock |
P - Purchase | 44 770 | 89 540 | 100,00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series B Warrant to Purchase Common Stock |
P - Purchase | 44 770 | 89 540 | 100,00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Warrant to Purchase Common Stock |
J - Other | 21 928 | 43 893 | 99,83 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Warrant to Purchase Common Stock |
J - Other | 8 275 | 21 965 | 60,45 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Warrant to Purchase Common Stock |
J - Other | 13 690 | 13 690 | |||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series C Preferred Stock |
C - Conversion | -10 416 | 0 | -100,00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series C Preferred Stock |
C - Conversion | -10 416 | 0 | -100,00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series C Preferred Stock |
C - Conversion | -48 885 | 20 832 | -70,12 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
2014 Convertible Promissory Notes |
S - Sale | -203 705 | 0 | -100,00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
2010/2012 Convertible Promissory Notes |
S - Sale | -555 250 | 0 | -100,00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
2010/2012 Convertible Promissory Notes |
S - Sale | -260 471 | 0 | -100,00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
2010/2012 Convertible Promissory Notes |
S - Sale | -471 192 | 0 | -100,00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 253 846 | 632 720 | 67,00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 44 770 | 378 874 | 13,40 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 114 072 | 334 104 | 51,84 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 53 512 | 220 032 | 32,14 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 96 803 | 166 520 | 138,85 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
C - Conversion | 10 416 | 69 717 | 17,56 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
C - Conversion | 10 416 | 69 717 | 17,56 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
C - Conversion | 48 885 | 48 885 | |||||
2014-11-14 |
|
4 | CAPN |
Capnia, Inc.
Employee Stock Option |
A - Award | 7 000 | 56 772 | 14,06 | ||||
2014-11-14 |
|
4 | CAPN |
Capnia, Inc.
Employee Stock Option |
A - Award | 49 772 | 56 772 | 711,03 | ||||
2014-11-12 | 3 | CAPN |
Capnia, Inc.
No securities beneficially owned |
0 | ||||||||
2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 10 000 | 106 053 | 10,41 | 29,00 | 290 000 | 3 075 537 | |
2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -517 | 1 033 | -33,35 | ||||
2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -3 000 | 6 000 | -33,33 | ||||
2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -5 282 | 47 535 | -10,00 | ||||
2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 517 | 96 053 | 0,54 | 23,26 | 12 025 | 2 234 193 | |
2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 3 000 | 95 536 | 3,24 | 23,26 | 69 780 | 2 222 167 | |
2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 5 282 | 92 536 | 6,05 | 5,05 | 26 674 | 467 307 | |
2014-11-04 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10 000 | 271 032 | -3,56 | 13,30 | -132 998 | 3 604 671 |
2014-11-03 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
A - Award | 13 177 | 281 032 | 4,92 | ||||
2014-10-31 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 5 000 | 5 000 | |||||
2014-10-29 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -100 000 | 129 358 | -43,60 | 102,85 | -10 284 630 | 13 303 992 | |
2014-10-09 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10 000 | 267 855 | -3,60 | 12,06 | -120 600 | 3 230 331 |
2014-09-29 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Series A common stock purchase warrant |
X - Other | -10 000 | 30 000 | -25,00 | ||||
2014-09-29 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
X - Other | 10 000 | 136 472 | 7,91 | 4,25 | 42 500 | 580 006 | |
2014-09-08 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 10 000 | 87 254 | 12,94 | 23,19 | 231 872 | 2 023 176 | |
2014-09-03 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10 000 | 277 855 | -3,47 | 12,60 | -125 992 | 3 500 751 |
2014-09-03 |
|
4 | Kin |
Kindred Biosciences, Inc.
Common Stock |
P - Purchase | 10 000 | 52 500 | 23,53 | 10,55 | 105 493 | 553 838 | |
2014-08-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Series A common stock purchase warrant |
X - Other | -7 059 | 40 000 | -15,00 | ||||
2014-08-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
X - Other | 7 059 | 126 472 | 5,91 | 4,25 | 30 001 | 537 506 | |
2014-08-27 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -8 803 | 52 817 | -14,29 | ||||
2014-08-27 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 8 803 | 77 254 | 12,86 | 5,05 | 44 455 | 390 133 | |
2014-08-06 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | -2 500 | 22 500 | -10,00 | ||||
2014-08-06 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 2 500 | 42 500 | 6,25 | 0,32 | 800 | 13 600 | |
2014-08-05 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10 000 | 287 855 | -3,36 | 12,58 | -125 817 | 3 621 705 |
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -5 000 | 7 666 | -39,48 | ||||
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 5 000 | 229 358 | 2,23 | 27,69 | 138 450 | 6 350 923 | |
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -196 | 2 574 | -7,08 | ||||
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -196 | 2 574 | -7,08 | ||||
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -2 210 | 2 770 | -44,38 | ||||
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -2 210 | 2 770 | -44,38 | ||||
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -1 020 | 4 980 | -17,00 | ||||
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -1 020 | 4 980 | -17,00 | ||||
2014-07-02 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10 000 | 297 855 | -3,25 | 12,95 | -129 468 | 3 856 269 |
2014-07-02 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 2 200 | 2 200 | |||||
2014-07-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 20 700 | 20 700 | |||||
2014-06-24 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 1 550 | 1 550 | |||||
2014-06-24 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 9 000 | 9 000 | |||||
2014-06-19 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 5 000 | 5 000 | |||||
2014-06-17 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock unit |
A - Award | 5 000 | 5 000 | |||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 055 | 113 892 | 1,84 | ||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -2 055 | 0 | -100,00 | ||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -3 100 | 0 | -100,00 | ||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 3 100 | 111 837 | 2,85 | ||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -1 033 | 1 034 | -49,98 | ||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 033 | 108 737 | 0,96 | ||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -1 033 | 2 067 | -33,32 | ||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 033 | 107 704 | 0,97 | ||||
2014-06-11 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock option |
A - Award | 15 000 | 15 000 | |||||
2014-06-03 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10 000 | 307 855 | -3,15 | 12,88 | -128 790 | 3 964 865 |
2014-05-28 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 10 000 | 68 451 | 17,11 | 14,22 | 142 200 | 973 373 | |
2014-05-27 |
|
4 | XNPT |
XENOPORT INC
Common Stock |
P - Purchase | 30 000 | 83 750 | 55,81 | 3,73 | 111 978 | 312 605 | |
2014-05-23 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | -2 500 | 25 000 | -9,09 | ||||
2014-05-23 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 2 500 | 40 000 | 6,67 | 0,32 | 800 | 12 800 | |
2014-05-16 |
|
4 | XNPT |
XENOPORT INC
Non-employee direct stock unit |
M - Exercise | -5 000 | 0 | -100,00 | ||||
2014-05-16 |
|
4 | XNPT |
XENOPORT INC
Common Stock |
M - Exercise | 5 000 | 53 750 | 10,26 | ||||
2014-05-02 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10 000 | 317 855 | -3,05 | 12,58 | -125 836 | 3 999 760 |
2014-04-08 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -6 000 | 6 333 | -48,65 | ||||
2014-04-08 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 6 000 | 106 671 | 5,96 | 55,38 | 332 280 | 5 907 440 | |
2014-04-02 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10 000 | 327 855 | -2,96 | 13,55 | -135 527 | 4 443 320 |
2014-04-01 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -7 047 | 61 620 | -10,26 | ||||
2014-04-01 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 7 047 | 58 451 | 13,71 | 5,05 | 35 587 | 295 178 | |
2014-03-05 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10 000 | 337 855 | -2,87 | 12,98 | -129 755 | 4 383 838 |
2014-02-26 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 5 500 | 5 500 | |||||
2014-02-07 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | -17 104 | 347 855 | -4,69 | 12,80 | -218 935 | 4 452 614 | |
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -6 875 | 0 | -100,00 | ||||
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -4 625 | 0 | -100,00 | ||||
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -2 000 | 0 | -100,00 | ||||
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -13 500 | 100 671 | -11,82 | 151,87 | -2 050 284 | 15 289 197 | |
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 6 875 | 114 171 | 6,41 | 60,02 | 412 638 | 6 852 543 | |
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 625 | 107 296 | 4,50 | 67,75 | 313 344 | 7 269 304 | |
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 000 | 102 671 | 1,99 | 59,89 | 119 780 | 6 148 966 | |
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -7 000 | 6 875 | -50,45 | ||||
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 7 000 | 100 671 | 7,47 | 60,02 | 420 140 | 6 042 273 | |
2014-02-05 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | -12 500 | 27 500 | -31,25 | ||||
2014-02-05 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 12 500 | 37 500 | 50,00 | 0,32 | 4 000 | 12 000 | |
2014-02-05 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 37 000 | 37 000 | |||||
2014-02-04 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10 000 | 364 959 | -2,67 | 13,19 | -131 884 | 4 813 225 |
2014-01-09 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -2 000 | 2 000 | -50,00 | ||||
2014-01-09 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 000 | 93 671 | 2,18 | 59,89 | 119 780 | 5 609 956 | |
2014-01-08 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10 000 | 374 959 | -2,60 | 12,50 | -125 000 | 4 686 988 |
2013-12-30 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10 000 | 384 959 | -2,53 | 12,06 | -120 600 | 4 642 606 |
2013-12-13 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
P - Purchase | 25 000 | 25 000 | 7,00 | 175 000 | 175 000 | ||
2013-12-13 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 5 000 | 51 404 | 10,77 | 13,90 | 69 500 | 714 516 | |
2013-11-25 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 8 000 | 46 404 | 20,83 | 15,20 | 121 600 | 705 341 | |
2013-11-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -15 840 | 68 667 | -18,74 | ||||
2013-11-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 15 840 | 38 404 | 70,20 | 5,05 | 79 992 | 193 940 | |
2013-11-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 7 500 | 22 564 | 49,79 | 15,25 | 114 375 | 344 101 | |
2013-11-12 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | -20 445 | 0 | -100,00 | 11,73 | -239 857 | ||
2013-11-12 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | -115 200 | 394 959 | -22,58 | 11,73 | -1 351 503 | 4 633 580 | |
2013-10-28 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -6 000 | 4 000 | -60,00 | ||||
2013-10-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 6 000 | 91 671 | 7,00 | 59,89 | 359 340 | 5 490 176 | |
2013-09-30 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock option |
M - Exercise | -18 750 | 11 250 | -62,50 | ||||
2013-09-30 |
|
4 | XNPT |
XENOPORT INC
Common stock |
M - Exercise | 18 750 | 48 750 | 62,50 | 5,79 | 108 562 | 282 262 | |
2013-09-03 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 64 | 15 064 | 0,43 | 15,75 | 1 008 | 237 258 | |
2013-09-03 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 786 | 15 000 | 5,53 | 15,80 | 12 419 | 237 000 | |
2013-09-03 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 1 714 | 14 214 | 13,71 | 15,80 | 27 081 | 224 581 | |
2013-09-03 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 2 500 | 12 500 | 25,00 | 15,85 | 39 625 | 198 125 | |
2013-08-27 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 2 000 | 10 000 | 25,00 | 16,80 | 33 600 | 168 000 | |
2013-08-27 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 2 000 | 8 000 | 33,33 | 17,30 | 34 600 | 138 400 | |
2013-08-27 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 1 960 | 6 000 | 48,51 | 17,50 | 34 300 | 105 000 | |
2013-08-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 40 | 4 040 | 1,00 | 17,50 | 700 | 70 700 | |
2013-08-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 2 000 | 4 000 | 100,00 | 17,50 | 35 000 | 70 000 | |
2013-08-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 2 000 | 2 000 | 17,45 | 34 900 | 34 900 | ||
2013-08-15 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -4 625 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 625 | 85 671 | 5,71 | 54,35 | 251 369 | 4 656 219 | |
2013-08-15 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Series A common stock purchase warrant |
P - Purchase | 47 059 | 47 059 | |||||
2013-08-15 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 47 059 | 119 713 | 64,77 | ||||
2013-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -1 033 | 2 067 | -33,32 | ||||
2013-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 033 | 81 046 | 1,29 | ||||
2013-06-14 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 3 100 | 3 100 | |||||
2013-06-14 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 9 300 | 9 300 | |||||
2013-06-07 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -15 000 | 10 000 | -60,00 | ||||
2013-06-07 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 15 000 | 80 013 | 23,07 | 59,89 | 898 350 | 4 791 979 | |
2013-05-30 |
|
4 | VVUS |
VIVUS INC
Common Stock |
P - Purchase | 15 000 | 81 125 | 22,68 | 14,68 | 220 206 | 1 190 947 | |
2013-05-30 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
P - Purchase | 400 | 65 013 | 0,62 | 123,73 | 49 493 | 8 044 189 | |
2013-05-30 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
P - Purchase | 600 | 64 613 | 0,94 | 123,72 | 74 232 | 7 993 920 | |
2013-05-23 |
|
4 | XNPT |
XENOPORT INC
Common Stock |
P - Purchase | 20 000 | 30 000 | 200,00 | 5,49 | 109 800 | 164 700 | |
2013-05-16 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock unit |
A - Award | 5 000 | 5 000 | |||||
2013-05-16 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock option |
A - Award | 15 000 | 15 000 | |||||
2013-05-08 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Phantom Stock |
A - Award | 22 756 | 130 098 | 21,20 | ||||
2013-05-08 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 30 000 | 509 304 | 6,26 | 7,76 | 232 800 | 3 952 199 | |
2013-04-29 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Warrants |
C - Conversion | -166 667 | 216 667 | -43,48 | ||||
2013-04-29 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock |
C - Conversion | 166 667 | 1 447 079 | 13,02 | 0,40 | 66 667 | 578 832 | |
2013-02-19 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 210 000 | 0 | -100,00 | ||||
2013-01-29 |
|
4 | VVUS |
VIVUS INC
Common Stock |
A - Award | 21 125 | 66 125 | 46,94 | ||||
2013-01-14 | 3 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, Par Value $0.001 |
1 280 412 | ||||||||
2012-08-21 |
|
4 | VVUS |
VIVUS INC
Common Stock |
P - Purchase | 5 000 | 45 000 | 12,50 | 20,75 | 103 750 | 933 750 | |
2012-08-13 |
|
4 | VVUS |
VIVUS INC
Common Stock |
P - Purchase | 5 000 | 40 000 | 14,29 | 21,50 | 107 500 | 860 000 | |
2012-08-13 |
|
4 | VVUS |
VIVUS INC
Common Stock |
P - Purchase | 15 000 | 35 000 | 75,00 | 21,83 | 327 399 | 763 931 | |
2012-08-09 |
|
4 | XNPT |
XENOPORT INC
Common Stock |
P - Purchase | 10 000 | 10 000 | 8,50 | 84 983 | 84 983 | ||
2012-08-08 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 32 000 | 479 304 | 7,15 | 5,29 | 169 280 | 2 535 518 | |
2012-06-19 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -685 | 0 | -100,00 | ||||
2012-06-19 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 685 | 64 013 | 1,08 | ||||
2012-06-18 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock option |
A - Award | 30 000 | 30 000 | |||||
2012-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 3 100 | 3 100 | |||||
2012-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 9 300 | 9 300 | |||||
2012-06-07 |
|
4 | MAXY |
MAXYGEN INC
Common Stock |
A - Award | 10 000 | 62 964 | 18,88 | ||||
2012-05-10 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Phantom Stock |
A - Award | 24 116 | 107 342 | 28,98 | ||||
2012-04-30 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -12 333 | 0 | -100,00 | ||||
2012-04-30 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -4 625 | 0 | -100,00 | ||||
2012-04-30 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 12 333 | 63 328 | 24,18 | 44,94 | 554 245 | 2 845 960 | |
2012-04-30 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 625 | 50 995 | 9,97 | 49,93 | 230 926 | 2 546 180 | |
2012-04-27 |
|
4 | VVUS |
VIVUS INC
Common Stock |
A - Award | 20 000 | 20 000 | |||||
2012-02-27 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 10 000 | 447 304 | 2,29 | 5,91 | 59 100 | 2 643 567 | |
2012-02-23 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 10 000 | 437 304 | 2,34 | 5,93 | 59 300 | 2 593 213 | |
2012-02-22 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 20 000 | 427 304 | 4,91 | 6,12 | 122 400 | 2 615 100 | |
2011-02-09 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 50 000 | 131 004 | 61,73 | 6,94 | 346 990 | 909 142 | |
2009-05-07 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Phantom Stock |
A - Award | 14 501 | 42 521 | 51,75 | ||||
2007-08-23 | 3 | CELG |
CELGENE CORP /DE/
Common Stock |
10 000 |